Press releases
- BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT
- BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE
- Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor
- BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS
- Canadian Investment Regulatory Organization Trade Resumption - BIOV
- BioVaxys Technology Corp. Announces Revocation of Cease Trade Order
- BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
- Canadian Investment Regulatory Organization Trading Halt - BIOV
- BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
- BioVaxys Technology Corp. Closes First Tranche of Private Placement
More ▼
Key statistics
On Tuesday, Biovaxys Technology Corp (BVAXF:QBB) closed at 0.0499, -34.17% below its 52-week high of 0.0758, set on Feb 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0411 |
---|---|
High | 0.051 |
Low | 0.0411 |
Bid | -- |
Offer | -- |
Previous close | 0.0499 |
Average volume | 169.59k |
---|---|
Shares outstanding | 220.24m |
Free float | 203.81m |
P/E (TTM) | -- |
Market cap | 13.80m CAD |
EPS (TTM) | -0.035 CAD |
Data delayed at least 15 minutes, as of Jul 23 2024 20:55 BST.
More ▼